Elevidys Costs $3.2 Million — Here's How Families Can Get Help

Let's be direct: Elevidys (Delandistrogene Moxeparvovec-rokl) has a wholesale acquisition cost (WAC) of approximately $3.2 million for a single, one-time treatment. That makes it one of the most expensive medications in the world.

If your child has Duchenne muscular dystrophy (DMD) and their doctor has recommended Elevidys, the price tag can feel insurmountable. But here's the important thing to understand: most families do not pay the full cost out of pocket. The vast majority of Elevidys treatments are covered through insurance, and there are financial assistance programs designed specifically to help families manage any remaining costs.

This guide covers what Elevidys actually costs, how insurance coverage works, and every financial resource available to help your family.

What Does Elevidys Cost Without Insurance?

The numbers:

• Wholesale acquisition cost (WAC): ~$3,200,000 per treatment
• This is a one-time cost — Elevidys is given as a single infusion, not an ongoing medication
• No generic or biosimilar exists — Elevidys is the only FDA-approved gene therapy for DMD
• The price is the same regardless of kit size — whether your child uses the 21.5-22.4 kg kit or a different weight band

Without insurance, the cost would be catastrophic for virtually any family. That's why insurance coverage and financial assistance are essential components of the access process.

How Insurance Covers Elevidys

Most families access Elevidys through their insurance plan — either commercial insurance, Medicaid, or a combination. Here's what to know:

Prior Authorization Is Required

Every insurance company requires prior authorization before covering Elevidys. This process involves:

• Submitting genetic test results confirming DMD
• Documenting ambulatory status
• Providing a letter of medical necessity from a specialist
• Peer-to-peer review between your child's neurologist and the insurance company's medical director

Initial Denials Are Common

Don't panic if the first authorization request is denied. For high-cost gene therapies, initial denials are common and don't necessarily mean the treatment won't be covered. The appeals process exists for this exact reason, and many families successfully obtain coverage through one or two rounds of appeals.

Medical Benefit vs. Pharmacy Benefit

Elevidys is typically classified as a medical benefit (not a pharmacy benefit) because it's administered as an infusion at a treatment center. This affects which part of your insurance handles the authorization and what your cost-sharing looks like. Medical benefits often have different deductible and out-of-pocket maximum structures than pharmacy benefits.

Out-of-Pocket Costs

Even with insurance approval, families may face significant out-of-pocket costs depending on their plan:

• Deductibles: You may need to meet your annual deductible first
• Coinsurance: Some plans require a percentage of the treatment cost (even a small percentage of $3.2 million is substantial)
• Out-of-pocket maximums: Federal law caps annual out-of-pocket costs for ACA-compliant plans, which provides some protection

SareptAssist: Your Primary Financial Resource

Sarepta Therapeutics offers a comprehensive patient support program called SareptAssist that is the most important financial resource for families seeking Elevidys. Services include:

• Insurance navigation: Help with prior authorization submissions, appeals, and understanding your coverage
• Financial assistance: Programs to help eligible families with out-of-pocket costs, copays, and coinsurance
• Treatment logistics: Coordination with treatment centers, scheduling support, and travel assistance
• Ongoing support: Continued assistance through the pre-treatment, infusion, and post-treatment monitoring phases

Contact SareptAssist at 1-888-727-3782 (1-888-SAREPTA). This should be one of your first calls after your child's doctor recommends Elevidys.

Traditional Coupons and Discount Cards Don't Apply

It's important to understand that Elevidys is not a pharmacy-dispensed medication. Traditional prescription drug coupons, discount cards, and programs like GoodRx, SingleCare, or RxSaver do not apply to gene therapies administered at treatment centers.

The financial assistance landscape for Elevidys is fundamentally different from a monthly prescription:

• No pharmacy coupons or discount cards available
• No generic alternative to seek lower pricing
• No mail-order or online pharmacy options
• Financial assistance comes through the manufacturer (SareptAssist), insurance, and charitable organizations

Other Financial Resources

Patient Advocacy Organizations

Several organizations offer financial support and navigation for DMD families:

• Parent Project Muscular Dystrophy (PPMD): Offers care navigation and can connect families with financial assistance resources. Visit parentprojectmd.org
• Muscular Dystrophy Association (MDA): Provides care center access and may offer financial assistance for qualifying families. Visit mda.org
• Jett Foundation: Provides direct support services for DMD families including financial aid

State and Federal Programs

• Medicaid: For eligible families, Medicaid may cover Elevidys. Coverage policies vary by state, and prior authorization is still required
• CHIP (Children's Health Insurance Program): May provide coverage for eligible children
• Patient Advocate Foundation: Offers case management for patients facing insurance barriers — visit patientadvocate.org

Hospital Financial Assistance

Many of the academic medical centers that serve as Elevidys treatment centers have their own financial assistance programs for patients facing hardship. Ask the treatment center's financial counselor about:

• Charity care programs
• Payment assistance
• Financial hardship applications
• Travel and lodging assistance for families traveling for treatment

Other Ways to Manage Costs

Maximize Your Insurance Benefits

• Review your plan's out-of-pocket maximum: For ACA-compliant plans, the 2026 out-of-pocket maximum provides a ceiling on your costs
• Time the treatment strategically: If possible, schedule the infusion early in your plan year so that the out-of-pocket spending also covers other medical costs throughout the year
• Understand your plan's accumulator adjustment policy: Some plans don't count manufacturer financial assistance toward your deductible or out-of-pocket maximum — know your plan's policy

Tax Considerations

Medical expenses exceeding 7.5% of your adjusted gross income may be tax-deductible. Keep detailed records of all expenses related to your child's DMD treatment, including:

• Travel costs to and from treatment centers
• Lodging for out-of-town treatment
• Copays and coinsurance payments
• Prescription costs for corticosteroids and other related medications

Consult a tax professional for guidance specific to your situation.

Final Thoughts

The $3.2 million price tag of Elevidys is staggering, but the financial assistance infrastructure around this treatment means that most families do not bear the full cost. Start with SareptAssist, work closely with your insurance company, and don't hesitate to reach out to patient advocacy organizations for help.

The process takes time and persistence, but financial barriers should not be the reason an eligible child doesn't receive treatment.

For more information, explore our articles on why Elevidys is hard to find, how to find Elevidys in stock, and the latest shortage update.